China Meheco Group Co

China Meheco Group Co FCF Yield

The Free Cash Flow Yield of China Meheco Group Co (600056.SS) as of Oct 23, 2026 is 6.92 %. In the previous year, Free Cash Flow Yield was 4.10 % — a change of 68.95% (higher).

FCF Yield

6.92 %

YoY

68.95%

Last updated:

Free Cash Flow Yield of China Meheco Group Co is 2025 6.92 % . Free Cash Flow Yield of China Meheco Group Co was 2024 4.10 % . It decreases by 68.95% higher compared to the previous year.

The China Meheco Group Co FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
-1.66 CNY
Jan 1, 2019
-2.12 CNY
Jan 1, 2020
7.87 CNY
Jan 1, 2021
-0.87 CNY
Jan 1, 2022
8.98 CNY
Jan 1, 2023
3.15 CNY
Jan 1, 2024
4.10 CNY
Jan 1, 2025
6.92 CNY
The China Meheco Group Co FCF Yield history
YEARFCF YieldYoY
6.92 %+68.95%
4.10 %+30.27%
3.15 %-64.96%
8.98 %-1,128.79%
-0.87 %-111.09%
7.87 %-471.55%
-2.12 %+27.71%
-1.66 %-165.33%
2.54 %-52.90%
5.39 %-4.90%
5.67 %-0.42%
5.69 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

China Meheco Group Co Stock analysis

What does China Meheco Group Co do? China Meheco Group Co., Ltd. generates revenue through its Industrial Pharmaceutical segment, which manufactures and distributes chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, and herbal decoction pieces. The Commercial Pharmaceutical segment focuses on wholesale and distribution of pharmaceuticals and medical devices. The Trading segment handles international exporting and medical resourcing introduction. The company serves healthcare providers, hospitals, and pharmacies through its wholesale operations, targeting the pharmaceutical and medical device markets in China and internationally. The Industrial Pharmaceutical segment produces chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, and herbal decoction pieces for distribution. The Commercial Pharmaceutical segment supplies pharmaceuticals and medical devices to healthcare institutions and retailers. The Trading segment facilitates international exports of pharmaceutical products and introduces medical resources globally, catering to global healthcare markets. China Meheco's revenue streams are derived from the sale of pharmaceutical products across its three segments. The Industrial segment manufactures and sells chemical and traditional Chinese medicine products, while the Commercial segment distributes these products through wholesale channels. The Trading segment earns from exporting pharmaceuticals and managing international medical resource procurement for global clients. China Meheco Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about China Meheco Group Co stock

Free Cash Flow Yield of China Meheco Group Co is 6.92 % in 2025.

Free Cash Flow Yield of China Meheco Group Co changed from 4.10 % to 6.92 %, representing a 68.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield China Meheco Group Co since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's China Meheco Group Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — China Meheco Group Co

All Key Metrics — China Meheco Group Co